View Older Stories View More Recent Stories
-
Lazard Declares Quarterly Dividend of $0.50 Per Share
-
Great Lakes Dredge & Dock (GLDD) Announces $150M Second-Lien Financing Agreement
-
Great Lakes Announces New $150,000,000 Second-Lien Financing Agreement
-
Sibelco to enter North American glass recycling industry with acquisition of Strategic Materials, Inc.
-
Lazard Global Total Return and Income Fund Declares Monthly Distribution and Issues Estimated Sources of the Distribution Announced in March
-
CEL-SCI Corp (CVM) Appoints Mario Gobbo to Its Board
-
CEL-SCI Appoints Mario Gobbo to Its Board of Directors
-
1847 Executes Letter of Intent to Sell 1847 Cabinets Inc. for $27.6 Million
-
TGH North Announces TGH Brooksville and TGH Spring Hill Board of Managers
-
TGH North Announces TGH Crystal River Board of Managers
-
DalFort Capital Partners ("DFCP") Announces Sale of United Enertech, to Soler & Palau Ventilation, Inc. ("S&P")
-
Form D/A K2 Lazard Liquid Convert
-
William H. Reinhardt Elected Vice President – Research, Adams Diversified Equity Fund
-
Lazard and Elaia Partners Form Strategic Partnership, Including the Launch of Lazard Elaia Capital, a Technology Focused Private Equity Investment Platform
-
1847 Reports 59.2% Increase in Revenue to $15.1 Million for the Fourth Quarter of 2023
-
UL Standards & Engagement Announces Net Proceeds from UL Solutions Initial Public Offering
-
UL Standards & Engagement Announces Net Proceeds from UL Solutions Initial Public Offering
-
The Government of the Republic of Ghana and representatives of Bondholders held constructive private discussions between 16th March and 12th April 2024
-
Form 485BPOS LAZARD RETIREMENT SERIES
-
Form D/A Lazard MENA Equity Fund
-
Lazard to Announce First Quarter 2024 Financial Results
-
JPMorgan profit beats estimates even as interest income misses predictions
-
Century Therapeutics (IPSC) to Acquire Clade Therapeutics, Announces $60M Private Placement
-
Century Therapeutics Strengthens Position in Autoimmune Disease with Strategic Pipeline Expansion Supported by $60 Million Private Placement and Acquisition of Clade Therapeutics
-
Vertex (VRTX) Enters Into Agreement to Acquire Alpine Immune Sciences (ALPN)
-
Vertex Enters Into Agreement to Acquire Alpine Immune Sciences
-
Inverness Graham Announces Sale of Vista Apex
-
Lazard (LAZ) Reports March 2024 Assets Under Management
-
Lazard Reports March 2024 Assets Under Management
-
Form 497 LAZARD FUNDS INC
-
CMD Global Partners Expands Corporate Advisory Practice in New York and Chicago
-
Form 497 LAZARD FUNDS INC
-
Lazard (LAZ) PT Raised to $52 at JMP Securities, 'a “value play”'
-
Houlihan Lokey (HLI) Continues Expansion of Its Capital Markets Group With Senior Hire
-
Houlihan Lokey Continues Expansion of Its Capital Markets Group With Senior Hire
-
Gain Therapeutics (GANX) Bolsters Management Team with the Appointment of Gene Mack as Chief Financial Officer
-
Gain Therapeutics Bolsters Management Team with the Appointment of Gene Mack as Chief Financial Officer
-
1847 Holdings to Acquire a Commercial Cabinet, Door & Millwork Manufacturer with Revenues of $28.6 Million and $5.2 Million of EBITDA in 2023
-
JPMorgan names CEO Dimon's potential successors including Piepszak, Lake
-
Apollo (APO) -Backed Mobile Internet Company Anuvu Engages Lazard for Asset Sale - WSJ
-
Lambda secures $500 million loan with Nvidia chips as collateral
-
Houlihan Lokey Continues Expansion of Private Funds Advisory Capabilities With Senior Hires for U.S. Primary Practice
-
Lambda Announces $500M GPU-Backed Facility to Expand Cloud for AI
-
Form DEFA14A Lazard, Inc.
-
XOMA Corporation Announces Closing of Tender Offer
-
Oppenheimer (OPY) Appoints William Bird as Director of Equity Research
-
Oppenheimer & Co. Inc. Appoints William Bird Director of Equity Research
-
Kingswood Capital Management Acquires PATCO Products, Formerly Corbion's Caravan Emulsifiers Division
-
David Higley Joins Perella Weinberg as Partner
-
Corbion and Kingswood Capital Management announce the completion of the divestiture of the emulsifier business
